Purchase Order W81K0025PA194
- Not listed
- This contract award is for the delivery of a Cardiogen-82 generator, infusion system and accessories, as well as a HeartSee license, to the William Beaumont Army Medical Center. The award was made on October 1, 2023 to Bracco Diagnostics Inc., a foreign-owned, for-profit organization that specializes in diagnostic imaging products and services for the U.S. federal government. The contract has a ceiling value of $386,597.90 and is a firm fixed-price purchase order. It is not associated with a...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $409,650.92 firm fixed price delivery order to Bracco Diagnostics Inc., a foreign-owned for-profit organization, for the supply of CARDIOGEN-82. The delivery order was placed against Bracco's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, and the products will be delivered to VA facilities within Veterans Integrated Service Network 17 located in Dallas, TX. Bracco Diagnostics is a...
- This federal contract award is for the delivery of a Cardio Generation and Infusion System to support medical imaging for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) in North Texas. The prime contractor is Bracco Diagnostics Inc., a foreign-owned for-profit organization that provides diagnostic imaging products and services. The contract was awarded on a Firm Fixed Price basis under Bracco's Pharmaceuticals and Drugs Federal Supply Schedule contract, with a...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract valued at $118,272.01 to Bracco Diagnostics Inc., a foreign-owned for-profit organization. The contract is issued under Bracco's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and provides generators, radioactive tracers, contrast media, imaging equipment, and associated accessories to support medical imaging across the VA and Defense Health Agency networks. Bracco,...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Bracco Diagnostics Inc., a foreign-owned, for-profit organization, for the delivery of Cardiogen Rubidium RB-82 Generators. The $407,843.50 contract has an ultimate completion date of September 30, 2025. It is not associated with a set-aside program. Bracco Diagnostics is a global healthcare company that specializes in diagnostic imaging products and medical technologies, particularly in nuclear...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bracco Diagnostics Inc., a foreign-owned for-profit company. The contract is for the provision of a generator, a medical imaging device, with a potential value of $488,761.70. The order is placed against Bracco's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA. The contract has no set-aside designation. Bracco Diagnostics Inc. is a leading...
- This is a delivery order awarded to Bracco Diagnostics Inc., a foreign-owned for-profit organization, under the Department of Veterans Affairs (VA) Veterans Health Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $735,032.77 firm fixed price order is for the supply of CARDIOGEN-82 rubidium generators used in cardiac positron emission tomography (PET) scans. Bracco Diagnostics, a leader in diagnostic imaging, provides a variety of radiopharmaceutical...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 17, to Bracco Diagnostics Inc., a foreign-owned, for-profit organization headquartered in Italy. The contract is for the supply of a PET rubidium-82 generator and associated medical supplies to support cardiac imaging services for the VA North Texas Health Care System in Dallas, Texas. The total ceiling value of the contract is $1,788,285.83, with a...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a firm fixed price delivery order to Bracco Diagnostics Inc., a foreign-owned for-profit organization, for the provision of a Rubidium Generator. The contract, which is valued at $334,554.00, is issued under Bracco's existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. Bracco, an international healthcare company, supplies a variety of radiopharmaceutical products, including...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bracco Diagnostics Inc., a foreign-owned for-profit organization, under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $359,763.30 award is for the lease of CARDIOGEN-82 infusion systems, accessories, and supplies to support cardiac PET scans at VA facilities in the Veterans Integrated Service Network 17 region. Bracco Diagnostics is...
The Defense Health Agency has awarded a $2.32 million firm fixed-price purchase order to Bracco Diagnostics Inc., a foreign-owned medical imaging equipment supplier headquartered in Italy. This contract, awarded on October 1, 2025, covers the provision of Cardiogen-82 generators and HeartSee software, with performance to be completed by September 30, 2030, in San Antonio, Texas. The award was made on a non-set-aside basis to support the federal healthcare system's cardiac imaging and diagnostic capabilities. Bracco Diagnostics is a specialized provider of radiopharmaceuticals, contrast media, and nuclear medicine imaging technologies, with extensive experience supplying the Department of Defense and Department of Veterans Affairs healthcare networks. The company's federal portfolio demonstrates a track record of delivering advanced diagnostic equipment such as positron emission tomography (PET) rubidium generators, infusion systems, and associated software across multiple VA Veterans Integrated Service Networks and the Defense Health Agency. This purchase order represents a continuation of Bracco's strategic role in enhancing cardiac imaging capabilities within federal healthcare delivery systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/8/25 |